Speakers

Expand/Collapse

Anna Podolanczuk
Assistant Professor - Pulmonary & Critical Care Medicine
Weill Cornell - Cornell University

Day One

Wednesday 14th June 2023

8:30 am | Panel Discussion – What is PPF? Delving into Defining Progression to Illuminate Research & Therapeutic Development for Progressive Fibroses

Day Two

Thursday 15th June 2023

8:30 am | Identifying & Highlighting Differences Between IPF & PPF to Inform Future Clinical Trial Endpoints

Annalisa Murgo
Researcher
Chiesi

Day Two

Thursday 15th June 2023

12:00 pm | Exploring the Consistency of Readouts Across Preclinical Models to Evaluate the Use of Novel Fibrosis Models in Preclinical Therapeutic Development

Cara Williams
Vice President, Head of Preclinical Biology, Inflammation, & Immunology
Pfizer

Day One

Wednesday 14th June 2023

8:25 am | Chair’s Opening Remarks

Chelsea Magin
Assistant Professor
University of Colorado

Day Two

Thursday 15th June 2023

1:30 pm | Engineering 3D Lung Models for Drug Discovery and Validation

Daniela Schloesser
Scientist
Boehringer Ingelheim

Day One

Wednesday 14th June 2023

12:00 pm | Targeting Macrophages to Create a Pro-Homeostatic Niche for Management of Fibrotic Disease

David (Yupeng) He
Project Lead Inflammation/Immunology
Abbvie

David Lynch
Radiologist
National Jewish Health

Day One

Wednesday 14th June 2023

2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs

9:00 am | Using Artificial Intelligence (AI) Techniques to Create an Estimate of Interstitial Lung Disease Progression

Elizabeth Volkmann
Associate Professor - Clinical & Medicine
UCLA Health Sciences

Francesco Del Galdo
Professor of Experimental Medicine
University Of Leeds

Day One

Wednesday 14th June 2023

10:00 am | Implementing a Precision Medicine Model to Stratify SSc-ILD Patients for 12 Months Risk of Progression

George Washko
Professor of Medicine
Harvard Medical School  

Day One

Wednesday 14th June 2023

4:30 pm | Honing an AI/Quantitative Method to Access the Accumulating Morphological & Clinical Imaging Knowledge for Clinical & Technical Practice

2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs

Harris Perlman
Professor & Chief of Rheumatology
Northwestern University

Day One

Wednesday 14th June 2023

2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs

1:30 pm | Uncovering the Role of Monocytes & Tissue Macrophages Across Fibrotic ILDs to Illuminate the Key Predictors of Progression

Janet Peper-Gabriel
Associate Director, Translational Research
Pieris Pharmaceuticals

Day Two

Thursday 15th June 2023

10:00 am | Transitioning Inhaled Preclinical Studies to the Clinic: Development of PRS-220, an Inhaled Anticalin Protein targeting CTGF/CCN2 for the Treatment of Lung Fibrosis

Karim El Kasmi
Senior Associate Director
Boehringer Ingelheim

Pre-Conference Day Track A AM

Tuesday 13th June 2023

9:00 am | Shining a Spotlight on the Lung Microenvironment to Delve into Cell Type Populations & the Extracellular Matrix

Kevin Hart
Associate Research Fellow (Scientific Director) - Fibrosis Exploratory Biology & Drug Discovery
Pfizer

Day One

Wednesday 14th June 2023

11:30 am | Identifying Scar-Associated Macrophages as Therapeutic Targets & Potential Biomarkers in Progressive Fibrosis

Madelyn Miller
Postdoctoral Scientist
El Lilly & Co

Day Two

Thursday 15th June 2023

2:30 pm | Oligonucleotides as Potential Therapies for Pulmonary Fibrosis

Mark Wilson
Principal Scientist
Genentech

Peter Fernandes
Chief Executive Officer
Bellerophon Therapeutics

Day Two

Thursday 15th June 2023

9:00 am | Adapting Clinical Trial Design & Endpoints for ILD Therapeutic Development: Harnessing Digital Health Technology (DHT) Endpoints

Rachel Knipe
Assistant Professor of Medicine, Harvard Medical School
Massachusetts general Hospital

Pre-Conference Day Track A AM

Tuesday 13th June 2023

1:00 pm | From ILD Risk Factors & Therapeutic Strategies to Clinical Endpoints: Hailing a New Era of Progressive Pulmonary Fibrosis Therapeutics

Resat Cinar
Co-Chief of Fibrotic Diseases
The National Institutes of Health

Day One

Wednesday 14th June 2023

8:30 am | Panel Discussion – What is PPF? Delving into Defining Progression to Illuminate Research & Therapeutic Development for Progressive Fibroses

Pre-Conference Day Track A AM

Tuesday 13th June 2023

9:00 am | Shining a Spotlight on the Lung Microenvironment to Delve into Cell Type Populations & the Extracellular Matrix

Rojo Ratsimandresy
Scientist - Biology Lead
Genentech

Day Two

Thursday 15th June 2023

2:00 pm | Reversing Translational Efforts to Identify New Pathways Contributing to ILD-Expanding the gp130-Dependent Cytokine Axis

Satish Madala
Professor & Basic Science Director
University of Cincinnati

Day Two

Thursday 15th June 2023

11:30 am | Using a Combination of Preclinical Models: The Way Forward for Mechanisms - Based Clinical Translation

Sydney Montessi
Assistant Professor of Medicine
Massachusetts General Hospital

Day One

Wednesday 14th June 2023

4:00 pm | Employing PET Probes in Early Phase Clinical Trials: From Target Engagement to Proof-Of-Concept

2:30 pm | Panel Discussion: Building a Biomarker Strategy for Effective Diagnostic, Predictive, & Prognostic Assessment Across ILDs

Vanessa Neiens
Biology Respiratory Lead
Pieris Pharmaceuticals

Xia Gao
Biomarker Scientist
Genentech

Day One

Wednesday 14th June 2023

9:30 am | Illuminating Biomarker Discovery in Systemic Sclerosis Associated ILD to Understand the Similarities to IPF

Yannick Allanore
Professor of Rheumatology
University of Paris Cité

Day One

Wednesday 14th June 2023

2:00 pm | Exploring the Role of Autoantibodies to Predict Outcomes of SSc-ILD